Wei Hung Chang
Direktor/Vorstandsmitglied bei EIRGENIX INC.
Ursprung des Netzwerks ersten Grades von Wei Hung Chang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Wei Hung Chang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| National Taiwan University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Masters Business Admin | |
| KINGPAK TECHNOLOGY INC. | Semiconductors | Director/Board Member | |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Pharmaceuticals: Major | Director/Board Member | |
| Yao Hwa Glass Co. Ltd. Management Committee | Corporate Officer/Principal | ||
| FORESEE PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Rochester Christian University | College/University | Doctorate Degree | |
| Pac-Link Bio Venture Capital Investment Corp. | Independent Dir/Board Member | ||
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
Cheng Xin Venture Capital Group
 Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Investment Managers | Investment Committee Member | |
| Michigan State University | College/University | Doctorate Degree | |
| REBER GENETICS CO LTD | Pharmaceuticals: Major | Director/Board Member | |
| Sheng Yang Venture Capital Co., Ltd. | Director/Board Member | ||
KGI Bank Co., Ltd.
 KGI Bank Co., Ltd. Major BanksFinance KGI Bank engages in the provision of financial services. Its business scopes include corporate finance, personal finance, financial market, and innovation and technology finance businesses. Its Corporate Finance business offers operations working capital loans, capital expenditure loans, trade finance, project financing, guarantee, and cash management services. Its Personal Finance business covers personal housing loans, credit loans, and dual card services. Its Financial Market business involves in the following activities: operation, transfer and management of foreign currency fund; management of interest rate on deposits; financial investment and trading; and sale of financial products. Its Innovation and Technology Finance business operates a digital financial service engine platform. The company was founded on January 14, 1992 and is headquartered in Taipei, Taiwan. | Major Banks | Corporate Officer/Principal | |
| KAISON GREEN ENERGY TECHNOLOGY CO., LTD | Motor Vehicles | Director/Board Member | |
| Fu Jen Catholic University | College/University | Undergraduate Degree | |
DBS Bank (Taiwan) Ltd.
 DBS Bank (Taiwan) Ltd. Major BanksFinance Part of DBS Group Holdings Ltd., DBS Bank (Taiwan) Ltd. is a financial institution based in Taipei, Taiwan. The Taiwanese company's description emphasizes their numerous prestigious awards, reflecting their growing strength and influence on the financial landscape throughout Taiwan. Sier Han Ng has been the CEO of the company since 2022. | Major Banks | Director/Board Member | |
| Kansas State University | College/University | Doctorate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
| University of New Haven | College/University | Graduate Degree | |
| PHARMAENGINE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| FORMOSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
| ASLAN PHARMACEUTICALS LIMITED | Biotechnology | Director/Board Member | |
| MYCENAX BIOTECH INC. | Biotechnology | Director/Board Member | |
| University of Wisconsin | College/University | Doctorate Degree | |
| Tsinghua University | College/University | Undergraduate Degree | |
| TWI PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
| LOTUS PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| MEDEON BIODESIGN, INC. | Electronic Equipment/Instruments | Director/Board Member | |
| TWI BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EXCELSIOR BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Allgenesis Biotherapeutics, Inc.
 Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Biotechnology | Founder | |
| Noratech Pharmaceuticals, Inc. | Director/Board Member | ||
Annji Pharmaceutical Co., Ltd.
 Annji Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Annji Pharmaceutical Co., Ltd. operates as a drug development company that produces small molecules for neurology, dermatology and inflammatory disorders. The company was founded on December 15, 2014 and is headquartered in Taipei, Taiwan. | Biotechnology | Director/Board Member | |
| FORMOSA LABORATORIES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| GLORY BIOTECH CO LTD | Biotechnology | Director/Board Member | |
| Ou Chia Szu Ta Investment Co. Ltd. | Director/Board Member | ||
| Mo Lo Chia Investment Co. Ltd. | Director/Board Member | ||
Rayoung Chemtech, Inc.
 Rayoung Chemtech, Inc. Chemicals: SpecialtyProcess Industries Rayoung Chemtech, Inc. manufactures chemical products. Its products include: dye liquid, specialty resins, wax, microbial control, aluminum anodizing dyes and sealing salt, additives in coating and Inks and additives for plastic and hot melt adhesive. The company was founded in 2008 and is headquartered in New Taipei, Taiwan. | Chemicals: Specialty | Director/Board Member | |
| University of Utah | College/University | Undergraduate Degree |
Statistik
International
| Taiwan | 33 |
| Vereinigte Staaten | 10 |
| Singapur | 3 |
| Cayman Islands | 2 |
| China | 2 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 13 |
| Electronic Technology | 4 |
| Finance | 4 |
| Consumer Durables | 2 |
Operativ
| Director/Board Member | 37 |
| Independent Dir/Board Member | 13 |
| Doctorate Degree | 9 |
| Undergraduate Degree | 4 |
| Graduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Wei Hung Chang
- Unternehmensverbindungen
